Skip to Content

CK21-01

Main Content

Haploidentical donor transplantation versus matched donor allogeneic hematopoietic cell transplantation outcomes in patients with myelofibrosis.

Study #: CK21-01

Study Status: Published

Presentation(s)

2023, Tandem (Oral)

Donor types and outcomes of transplantation in Myelofibrosis: A CIBMTR study.

Citation

Jain, T, Estrada-Merly N, Queralt Salas M, Kim S, DeVos J, Chen M, Fang X, Kumar R, Andrade-Campos M, Elmariah H, Agrawal V, Aljurf M, Ulrike Bacher V, Badar T, Badawy S, Ballen K, Beitinjaneh A, Bhatt V, Bredeson C, DeFilipp Z, Dholaria B, Farhadfar N, Farhan S, Gandhi A, Ganguly S, Gergis U, Grunwald M, Hamad N, Hamilton B, Inamoto Y, Iqbal M, Jamy O, Juckett M, Kharfan-Dabaja MA, Krem M, Lad D, Liesveld J, Al Malki M, Malone AK, Murthy H, Ortí G, Patel S, Pawarode A, Perales M, van der Poel M, Ringden O, Rizzieri D, Rovo A, Savani B, Savoie M, Seo S, Solh M, Ustun C, Verdonck L, Wingard J, Wirk B, Bejanyan N, Jones R, Nishihori T, Oran B, Nakamura R, Scott B, Saber W, Gupta V.

Blood Advances. 2024, Jun 13: (): . doi: 10.1182/bloodadvances.2024013451. Epub 2024, Apr 22. PMCID:.

PubMed

PMID: 38916866

Abstract